Co-Diagnostics Inc
NASDAQ:CODX
During the last 3 months Co-Diagnostics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 80% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/codx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Mar 20, 2023
by
Brown Brian Lee
, who
bought
5.7k USD
worth of
CODX shares.
During the last 3 months Co-Diagnostics Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 80% over this period ( loading = false, 5000)" href="https://www.alphaspread.com/comparison/nasdaq/codx/vs/indx/gspc">open performance analysis).
The last transaction was made on
Mar 20, 2023
by
Brown Brian Lee
, who
bought
5.7k USD
worth of
CODX shares.
Co-Diagnostics Inc
Glance View
Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company is headquartered in Salt Lake City, Utah and currently employs 101 full-time employees. The company went IPO on 2017-07-12. The firm is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. The company also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The firm uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.
What is Insider Trading?
Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.
While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.
Why is Insider Trading Important?
It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.
However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.
Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.